X4 Pharmaceuticals, Inc. buy Cantor Fitzgerald
Start price
31.05.24
/
50%
€0.93
Target price
31.05.25
€4.61
Performance (%)
-14.72%
Price
25.07.24
€0.79
Summary
This prediction is currently active. The price of X4 Pharmaceuticals, Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.72%. This prediction currently runs until 31.05.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| X4 Pharmaceuticals, Inc. | 47.721% | 47.721% |
| iShares Core DAX® | 0.039% | 0.567% |
| iShares Nasdaq 100 | -4.018% | -5.554% |
| iShares Nikkei 225® | -2.389% | -1.434% |
| iShares S&P 500 | -2.115% | -2.351% |
Comments by Cantor_Fitzgerald for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $5.00 price target on the stock.
Ratings data for XFOR provided by MarketBeat